why is the fda banning tirzepatide approval for Zepbound (tirzepatide) injection, first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly FDA Ban on Compounded GLP-1

The rapid rise of GLP-1 medications like semaglutide and tirzepatide has reshaped conversations about weight, health and appetitebut a lot of research hasnt been done on these new drugs

[2] Factors That Affect GLP-1 Response and Effectiveness Multiple patient-specific and lifestyle factors can significantly influence how well GLP-1 medications work

Three, it acts on the hypothalamus in the brain to decrease hunger

From supporting blood sugar control to promoting weight loss, progress builds over time

Additionally, the FDA approved oral semaglutide (Wegovy pill, 25 mg) for obesity in December 2025, marking the first GLP-1 pill for weight loss ( [19] )

Patients should be counseled about these potential side effects before initiating therapy and instructed on appropriate management strategies and warning signs that warrant medical evaluation